ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$22.57

Market cap

$11.28B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.41

Enterprise value

$14.98B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 33

Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating ...

Highlights
The gross profit has grown by 13% YoY and by 3.2% from the previous quarter
Elanco Animal Health's revenue has increased by 12% YoY and by 2.6% from the previous quarter
The company's EPS has shrunk by 147% YoY but it rose by 18% QoQ
Elanco Animal Health's net income has plunged by 146% YoY but it has increased by 18% from the previous quarter
The quick ratio has contracted by 23% YoY and by 4.2% from the previous quarter
ELAN's equity is down by 2.8% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.elanco.com
Peers: OPK ORGO

Key stats

What are the main financial stats of ELAN

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
-1.57%
1 week
-1.27%
1 month
-5.84%
1 year
21.74%
YTD
-0.27%
QTD
-8.29%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$5.02B
Gross profit
$2.78B
Operating income
$81M
Net income
-$199M
Gross margin
55.4%
Net margin
-4%
Elanco Animal Health's net income has plunged by 146% YoY but it has increased by 18% from the previous quarter
The net margin has dropped by 141% year-on-year but it is up by 18% since the previous quarter
The company's operating margin has shrunk by 59% YoY but it rose by 45% QoQ
Elanco Animal Health's operating income has plunged by 54% YoY but it has increased by 45% from the previous quarter

Price vs fundamentals

How does ELAN's price correlate with its fundamentals

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
ELAN P/E details
P/E
N/A
P/B
1.71
P/S
2.25
EV/EBIT
182.68
EV/EBITDA
19.33
EV/Sales
2.98
The company's EPS has shrunk by 147% YoY but it rose by 18% QoQ
The price to book (P/B) is 34% higher than the 5-year quarterly average of 1.3 and 2.4% higher than the last 4 quarters average of 1.7
ELAN's equity is down by 2.8% YoY
ELAN's P/S is 20% above its 5-year quarterly average of 1.9 but 5% below its last 4 quarters average of 2.4
Elanco Animal Health's revenue has increased by 12% YoY and by 2.6% from the previous quarter

Efficiency

How efficient is Elanco Animal Health business performance
The company's return on assets has shrunk by 145% YoY but it rose by 17% QoQ
Elanco Animal Health's ROE has plunged by 145% YoY but it has increased by 17% from the previous quarter
Elanco Animal Health's ROIC has soared by 120% from the previous quarter but it has plunged by 90% YoY
The company's return on sales has surged by 100% QoQ but it has shrunk by 91% YoY

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 94% higher than its total liabilities
The quick ratio has contracted by 23% YoY and by 4.2% from the previous quarter
Elanco Animal Health's current ratio has decreased by 21% YoY and by 5% from the previous quarter
The debt is 36% smaller than the equity
The debt is down by 6% year-on-year
The debt to equity has declined by 3% since the previous quarter and by 3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.